How Ethos Sold Wall Street on AI While Powering an Analog Boiler Room
Jenny Ahn, Michelle Cera, Ruth Reader, Hunterbrook
Amyloban 3399
March 2016: This action was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled.. The reasons have not been disclosed.
January 2016: A class-action lawsuit was filed against Mushroom Wisdom for allegedly deceptively marketing the supplement Amyloban 3399 as an effective therapy for the prevention of brain disease – including Alzheimer’s Disease – when, in reality, such claims are not true and in violation of federal law. The lawsuit was transferred to federal court in February 2016. (Hoffman et al v. Mushroom Wisdom, Inc., Case No. 16-cv-768, D. NJ.)
For more information about other class-action lawsuits regarding brain supplements and TINA.org’s coverage of the products, click here.
The Latest
CATrends: Unscented Deodorants and Antiperspirants
Lawsuits allege marketing doesn’t pass the smell test.
HydroJug’s Heat-Retention Claims
Can these bottles really keep drinks hot for up to six hours?
With Personalized Pricing, Disclosure Is a Start, But Not a Finish Line
TINA.org and other consumer advocates file comment with FTC.
MLMs Are Consistently Leaving Participants Behind
New book explores why MLMs are often associated with harmful outcomes – and what can be done about it.